Deeply invasive candidiasis, Infectious Disease Clinics of North America, vol.16, issue.4, pp.821-856, 2002. ,
DOI : 10.1016/S0891-5520(02)00034-X
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009. ,
DOI : 10.1086/596757
Invasive Candidiasis, New England Journal of Medicine, vol.373, issue.15, pp.1445-56, 2015. ,
DOI : 10.1056/NEJMra1315399
Invasive candidiasis Infect Dis Clin North Am, pp.485-506, 2006. ,
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France Crit Care Med, pp.1612-1620, 2005. ,
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus, Clinical Infectious Diseases, vol.34, issue.1, pp.7-14, 2002. ,
DOI : 10.1086/323335
Physiopathologie et diagnostic des candidoses systémiques. Lett Infect, pp.182-90, 2000. ,
Revisiting the source of candidemia: skin or gut? Clin Infect Dis Off Publ Infect Dis Soc Am, pp.1959-67, 2001. ,
Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care, p.37, 2011. ,
Clinical significance of the isolation of Candida species from hospitalized patients, Brazilian Journal of Microbiology, vol.46, issue.1, pp.117-140, 2015. ,
DOI : 10.1590/S1517-838246120120296
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients, The Lancet Infectious Diseases, vol.3, issue.11, pp.685-702, 2003. ,
DOI : 10.1016/S1473-3099(03)00801-6
Candidoses et levuroses diverses, EMC-Mal Infect, pp.1-15, 2005. ,
Candida spp. colonization significance in critically ill medical patients: a prospective study, Intensive Care Medicine, vol.36, issue.3, pp.393-400, 2005. ,
DOI : 10.1007/s00134-005-2571-y
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3, J Clin Microbiol, vol.37, issue.9, pp.2817-2845, 1999. ,
Candida albicans morphogenesis and host defence: discriminating invasion from colonization, Nature Reviews Microbiology, vol.139, 2012. ,
DOI : 10.1016/j.cell.2009.09.033
Epidemiology of invasive candidiasis, Current Opinion in Critical Care, vol.16, issue.5, pp.445-52, 2010. ,
DOI : 10.1097/MCC.0b013e32833e84d2
Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008???2013: Results from Population-Based Surveillance, PLOS ONE, vol.85, issue.1, p.120452, 2015. ,
DOI : 10.1371/journal.pone.0120452.t002
Population-based analysis of invasive fungal infections, Emerg Infect Dis. 2014, vol.20, issue.7, pp.1149-55, 2001. ,
Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program, Journal of Clinical Microbiology, vol.42, issue.4, 2004. ,
DOI : 10.1128/JCM.42.4.1519-1527.2004
Mycoses invasives en France métropolitaine : incidence, létalité et tendance, Bull Épidémiologique Hebd, pp.12-13109, 2001. ,
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area Intensive Care Med, pp.1303-1315, 2002. ,
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.309-326, 2004. ,
Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study, Crit Care Med, 2011. ,
Nosocomial candidemia in adults: Risk and prognostic factors, Journal de Mycologie M??dicale, vol.20, issue.4, pp.269-78, 2010. ,
DOI : 10.1016/j.mycmed.2010.07.006
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study, Intensive Care Medicine, vol.378, issue.12, pp.1930-1975, 2012. ,
DOI : 10.1016/S0140-6736(11)60401-7
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units, JAMA, vol.302, issue.21, pp.2323-2332, 2009. ,
DOI : 10.1001/jama.2009.1754
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, Clin Infect Dis Off Publ Infect Dis Soc Am Feb, vol.138, issue.3, pp.311-331, 1991. ,
Bench-to-bedside review: Candida infections in the intensive care unit, Critical Care, vol.12, issue.1, p.204, 2008. ,
DOI : 10.1186/cc6212
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care Lond Engl The epidemiology of candidemia in two United States cities: results of a population-based active surveillance, pp.1164-70, 1999. ,
URL : https://hal.archives-ouvertes.fr/inserm-00873494
The Danish Collaborative Bacteraemia Network (DACOBAN) database, Clinical Epidemiology, vol.6, pp.301-309, 2014. ,
DOI : 10.2147/CLEP.S66998
Multistate Point-Prevalence Survey of Health Care???Associated Infections, New England Journal of Medicine, vol.370, issue.13, pp.1198-208, 2014. ,
DOI : 10.1056/NEJMoa1306801
The global epidemiology of invasive Candida infections?is the tide turning? J Hosp Infect, pp.159-68, 2003. ,
Epidemiology and risk factors for invasive candidiasis, Therapeutics and Clinical Risk Management, vol.10, pp.95-105, 2014. ,
DOI : 10.2147/TCRM.S40160
??pid??miologie des candid??mies??: ??tude observationnelle prospective d???un an dans l???Ouest de la France, M??decine et Maladies Infectieuses, vol.39, issue.12, pp.877-85, 2009. ,
DOI : 10.1016/j.medmal.2009.02.008
Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting, Am J Infect Control Eur J Clin Microbiol Infect Dis, vol.3726, issue.4, pp.271-277, 2007. ,
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia, Journal of Clinical Microbiology, vol.49, issue.9, 2011. ,
DOI : 10.1128/JCM.00179-11
Epidemiology, risk factors and in vitro susceptibility in candidaemia due to non-Candida albicans species], Rev Iberoam Micol, 2016. ,
Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies, European Journal of Clinical Microbiology & Infectious Diseases, vol.38, issue.7, pp.419-444, 2006. ,
DOI : 10.1164/ajrccm.160.3.9808145
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality, Intensive Care Med, 2014. ,
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain, Clinical Microbiology and Infection, vol.20, issue.4, pp.245-254 ,
DOI : 10.1111/1469-0691.12380
endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis, Expert Review of Anti-infective Therapy, vol.54, issue.4, pp.807-825, 2017. ,
DOI : 10.1016/S0735-1097(00)01206-7
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality, Intensive Care Medicine, vol.45, issue.1, pp.1601-1611, 2015. ,
DOI : 10.1128/JCM.00131-07
Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3950-3956 ,
DOI : 10.1128/AAC.06258-11
Epidemiology and reporting of candidaemia in Belgium: a multi-centre study, European Journal of Clinical Microbiology & Infectious Diseases, vol.34, issue.3, 2016. ,
DOI : 10.1007/s10096-015-2322-0
Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years, Mycopathologia, vol.28, issue.50, 2017. ,
DOI : 10.1097/QCO.0000000000000215
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy, European Journal of Internal Medicine, vol.34, pp.39-44, 2016. ,
DOI : 10.1016/j.ejim.2016.08.020
Changing epidemiology of systemic fungal infections, Clinical Microbiology and Infection, vol.14, issue.4, pp.5-24, 2008. ,
DOI : 10.1111/j.1469-0691.2008.01978.x
Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK, International Journal of Infectious Diseases, vol.15, issue.11, pp.759-763, 2011. ,
DOI : 10.1016/j.ijid.2011.06.006
Invasive fungal infections: a review of epidemiology and management options, Journal of Medical Microbiology, vol.55, issue.7, pp.809-827, 2006. ,
DOI : 10.1099/jmm.0.46548-0
Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011, Antimicrobial Agents and Chemotherapy, vol.58, issue.3, pp.1529-1566, 2010. ,
DOI : 10.1128/AAC.02155-13
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion, Journal of Clinical Microbiology, vol.48, issue.4, pp.1366-77, 1997. ,
DOI : 10.1128/JCM.02117-09
Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011, Journal of Clinical Microbiology, vol.50, issue.11, pp.3435-3477, 2008. ,
DOI : 10.1128/JCM.01283-12
Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.561-70, 2010. ,
Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey, PLoS ONE, vol.55, issue.1981, p.59373, 2013. ,
DOI : 10.1371/journal.pone.0059373.t005
Candidaemia in internal medicine departments: the burden of a rising problem, Clinical Microbiology and Infection, vol.19, issue.6, pp.281-284 ,
DOI : 10.1111/1469-0691.12155
Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain, Journal of Clinical Microbiology, vol.51, issue.12, pp.4167-72, 2013. ,
DOI : 10.1128/JCM.01998-13
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-63, 2007. ,
DOI : 10.1128/CMR.00029-06
The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med, 2017. ,
Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp., Critical Care Medicine, vol.36, issue.7, pp.2034-2043, 2008. ,
DOI : 10.1097/CCM.0b013e3181760f42
Candida albicans versus nonalbicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit, Feb, vol.10646, issue.638, pp.523-5291206, 2008. ,
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.18, pp.1-8, 2012. ,
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.18, pp.19-37, 2012. ,
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.18, issue.7, pp.9-18, 2012. ,
In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model, Infection, vol.30, issue.5, pp.286-91, 2002. ,
DOI : 10.1007/s15010-002-2131-0
Microsatellite multilocus genotyping clarifies the relationship of Candida parapsilosis strains involved in a neonatal intensive care unit outbreak, Diagnostic Microbiology and Infectious Disease, vol.71, issue.2, pp.159-62, 2011. ,
DOI : 10.1016/j.diagmicrobio.2011.05.014
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia, The Journal of Infectious Diseases, vol.205, issue.6, pp.934-977, 2012. ,
DOI : 10.1093/infdis/jir867
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia, Nature Communications, vol.37, p.4675, 2014. ,
DOI : 10.1038/ng1617
URL : https://hal.archives-ouvertes.fr/hal-01064610
Immunotherapy, Current Opinion in Infectious Diseases, vol.27, issue.6, pp.511-517, 2014. ,
DOI : 10.1097/QCO.0000000000000105
Phylogenetic Perspectives in Innate Immunity, Science, vol.284, issue.5418, pp.1313-1321, 1999. ,
DOI : 10.1126/science.284.5418.1313
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.62, issue.4, pp.409-426, 2016. ,
DOI : 10.1093/cid/civ1194
Finding the ???Missing 50%??? of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care, Clinical Infectious Diseases, vol.56, issue.9, pp.1284-92, 2013. ,
DOI : 10.1093/cid/cit006
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, pp.3640-3645, 2005. ,
DOI : 10.1128/AAC.49.9.3640-3645.2005
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.25-31, 2006. ,
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.1589-96, 2006. ,
DOI : 10.1097/01.CCM.0000217961.75225.E9
Excess Risk of Death from Intensive Care Unit--Acquired Nosocomial Bloodstream Infections: A Reappraisal, Clinical Infectious Diseases, vol.42, issue.8, pp.1118-1144, 2006. ,
DOI : 10.1086/500318
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control, Clinical Infectious Diseases, vol.54, issue.12, pp.1739-1785 ,
DOI : 10.1093/cid/cis305
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance, Journal of Infection, vol.71, issue.3, pp.385-94, 2015. ,
DOI : 10.1016/j.jinf.2015.05.009
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain, Clinical Microbiology and Infection, vol.20, issue.4, pp.245-254 ,
DOI : 10.1111/1469-0691.12380
Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med, pp.813-835, 2012. ,
MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting, Clinical Infectious Diseases, vol.58, issue.9, pp.1219-1245, 2014. ,
DOI : 10.1093/cid/ciu074
The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients, Diagnostic Microbiology and Infectious Disease, vol.55, issue.4, pp.293-301, 2006. ,
DOI : 10.1016/j.diagmicrobio.2006.03.013
Candida Colonization and Subsequent Infections in Critically III Surgical Patients, Annals of Surgery, vol.220, issue.6, pp.751-759, 1994. ,
DOI : 10.1097/00000658-199412000-00008
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients(*), Critical Care Medicine, vol.32, issue.12, pp.2443-2452, 2004. ,
DOI : 10.1097/01.CCM.0000147726.62304.7F
Usefulness of the ???Candida score??? for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study, Critical Care Medicine, vol.37, issue.5, pp.1624-1657, 2009. ,
DOI : 10.1097/CCM.0b013e31819daa14
A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*, Critical Care Medicine, vol.34, issue.3, pp.730-737, 2006. ,
DOI : 10.1097/01.CCM.0000202208.37364.7D
Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome, Intensive Care Medicine, vol.36, issue.2, pp.292-301, 2008. ,
DOI : 10.1093/infdis/168.1.195
Candida Colonization of the Respiratory Tract and Subsequent Pseudomonas Ventilator-Associated Pneumonia, Chest, vol.129, issue.1, pp.110-117, 2006. ,
DOI : 10.1378/chest.129.1.110
Candida colonization index and subsequent infection in critically ill surgical patients: 20??years later, Intensive Care Medicine, vol.42, issue.Suppl 7, pp.1429-1477, 2014. ,
DOI : 10.1097/CCM.0000000000000208
Evaluation of 'Candida score' in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care, p.50, 2011. ,
Evaluation of the predictive indices for candidemia in an adult intensive care unit. Rev Soc Bras Med Trop, 2015. ,
Detection and identification of Candida sp. by PCR in candidemia diagnosis, Journal de Mycologie M??dicale, vol.17, issue.4, pp.256-60, 2007. ,
DOI : 10.1016/j.mycmed.2007.10.001
?-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3) Clin Infect Dis Off Publ Infect Dis Soc Am, pp.633-676, 2012. ,
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia, Third European Conference on Infections in Leukemia Group, p.222, 2010. ,
DOI : 10.1128/CVI.00200-08
URL : https://hal.archives-ouvertes.fr/inserm-00663709
ESCMID??? and ECMM??? joint clinical guidelines for the diagnosis and management of rare invasive yeast infections, Clinical Microbiology and Infection, vol.20, pp.76-98 ,
DOI : 10.1111/1469-0691.12360
Correlation of Clinical Outcomes with ??-Glucan Levels in Patients with Invasive Candidiasis, Journal of Clinical Microbiology, vol.50, issue.6, 2012. ,
DOI : 10.1128/JCM.00773-12
?-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.750-70, 2011. ,
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts, Intensive Care Medicine, vol.46, issue.3, pp.2092-106, 2013. ,
DOI : 10.1128/JCM.02091-07
What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med, pp.808-827, 2014. ,
Prospective Survey of (1->3)-??-D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting, Journal of Clinical Microbiology, vol.49, issue.1, pp.58-61, 2011. ,
DOI : 10.1128/JCM.01240-10
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1???3)-??-D-glucan assay, Candida score, and colonization index, Critical Care, vol.15, issue.5, p.249, 2011. ,
DOI : 10.1007/s10096-004-1104-x
Clinical Performance of the (1,3)-??-D-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections, Clinical and Vaccine Immunology, vol.18, issue.12, pp.2113-2120, 2011. ,
DOI : 10.1128/CVI.05408-11
Value of ??-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions, Intensive Care Medicine, vol.54, issue.8, 2012. ,
DOI : 10.1093/cid/cis200
??-Glucan Antigenemia Anticipates Diagnosis of Blood Culture???Negative Intraabdominal Candidiasis, American Journal of Respiratory and Critical Care Medicine, vol.34, issue.9, pp.1100-1109, 2013. ,
DOI : 10.1371/journal.pone.0042282
??-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study, PLoS ONE, vol.7, issue.8, p.42282, 2012. ,
DOI : 10.1371/journal.pone.0042282.s002
??-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis, Intensive Care Medicine, vol.16, issue.Suppl 1, pp.1424-1456, 2015. ,
DOI : 10.1128/CVI.00183-09
Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation, Critical Care, vol.18, issue.3, p.135, 2014. ,
DOI : 10.1097/CCM.0b013e31819daa14
Clinical factors associated with a Candida albicansGerm Tube Antibody positive test in Intensive Care Unit patients, BMC Infectious Diseases, vol.34, issue.1, p.60, 2009. ,
DOI : 10.1097/01.CCM.0000202435.98240.ED
Candida biomarkers in patients with candidaemia and bacteraemia, J Antimicrob Chemother, 2015. ,
Comparison of (1->3)-??-D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia, Journal of Clinical Microbiology, vol.51, issue.4, pp.1158-64 ,
DOI : 10.1128/JCM.02473-12
Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment, J Antimicrob Chemother, 2015. ,
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis, Journal of Clinical Microbiology, vol.49, issue.2, pp.665-70, 2011. ,
DOI : 10.1128/JCM.01602-10
Performance of Candida Real-time Polymerase Chain Reaction, ??-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis, Clinical Infectious Diseases, vol.54, issue.9, 2012. ,
DOI : 10.1093/cid/cis200
Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients, Journal of Antimicrobial Chemotherapy, vol.69, issue.11, pp.3134-3175, 2014. ,
DOI : 10.1093/jac/dku225
Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis ??? A Systemic Review and Meta-Analysis, PLoS ONE, vol.224, issue.5, p.62323, 2013. ,
DOI : 10.1371/journal.pone.0062323.s003
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial, Clinical Infectious Diseases, vol.60, issue.6, pp.892-901, 2015. ,
DOI : 10.1093/cid/ciu959
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials, Clinical Infectious Diseases, vol.54, issue.8, pp.1110-1132 ,
DOI : 10.1093/cid/cis021
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*, Critical Care Medicine, vol.42, issue.6, pp.1423-1455 ,
DOI : 10.1097/CCM.0000000000000221
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients, Annals of Internal Medicine, vol.149, issue.2, pp.83-90, 2008. ,
DOI : 10.7326/0003-4819-149-2-200807150-00004
Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU, BMC Infectious Diseases, vol.7, issue.8, p.385, 2014. ,
DOI : 10.1371/journal.pone.0042282
Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients, Intensive Care Medicine, vol.55, issue.12, pp.2141-2146, 2009. ,
DOI : 10.1007/s00134-009-1619-9
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial, Trials, vol.14, issue.1, p.399, 2013. ,
DOI : 10.1093/jac/dkr394
URL : https://hal.archives-ouvertes.fr/inserm-00913515
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations, Clinical Infectious Diseases, vol.56, issue.12, pp.1724-1756, 2013. ,
DOI : 10.1093/cid/cit136
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.819-844, 2014. ,
Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure, Antimicrobial Agents and Chemotherapy, vol.57, issue.8, pp.3528-3563, 2013. ,
DOI : 10.1128/AAC.00136-13
Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia, Journal of Clinical Microbiology, vol.54, issue.3, pp.718-744, 2016. ,
DOI : 10.1128/JCM.02971-15
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia, New England Journal of Medicine, vol.331, issue.20, pp.1325-1355, 1994. ,
DOI : 10.1056/NEJM199411173312001
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis, New England Journal of Medicine, vol.347, issue.25, pp.2020-2029, 2002. ,
DOI : 10.1056/NEJMoa021585
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial, The Lancet, vol.366, issue.9495, pp.1435-1477, 2005. ,
DOI : 10.1016/S0140-6736(05)67490-9
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial, The Lancet, vol.369, issue.9572, pp.1519-1546, 2007. ,
DOI : 10.1016/S0140-6736(07)60605-9
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.883-93, 2007. ,
Anidulafungin versus Fluconazole for Invasive Candidiasis, New England Journal of Medicine, vol.356, issue.24, pp.2472-82, 2007. ,
DOI : 10.1056/NEJMoa066906
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome, BMC Infectious Diseases, vol.17, issue.Suppl 1, p.261, 2011. ,
DOI : 10.1016/0732-8893(93)90020-8
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study, Journal of Antimicrobial Chemotherapy, vol.68, issue.4, pp.922-928 ,
DOI : 10.1093/jac/dks482
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients, Clinical Microbiology and Infection, vol.18, issue.7, pp.680-687 ,
DOI : 10.1111/j.1469-0691.2012.03784.x
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial, BMC Infectious Diseases, vol.46, issue.Suppl 7, p.97, 2014. ,
DOI : 10.1128/JCM.00566-08
Combination Antifungal Therapy, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.693-715, 2004. ,
DOI : 10.1128/AAC.48.3.693-715.2004
Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review, International Journal of Antimicrobial Agents, vol.39, issue.1, pp.1-10 ,
DOI : 10.1016/j.ijantimicag.2011.07.013
A Randomized and Blinded Multicenter Trial of High???Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects, Clinical Infectious Diseases, vol.36, issue.10, pp.1221-1229, 2003. ,
DOI : 10.1086/374850
Duration of antifungal treatment and development of delayed complications in patients with candidaemia ,
Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials, Clinical Infectious Diseases, vol.51, issue.3, pp.295-303, 2010. ,
DOI : 10.1086/653935
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials, European Journal of Clinical Microbiology & Infectious Diseases, vol.45, issue.2, pp.223-232, 2010. ,
DOI : 10.3201/eid0908.030069
Should the guidelines for management of central venous catheters in patients with candidemia be changed now? Clin Infect Dis Off Publ Infect Dis Soc Am, pp.304-310, 2010. ,
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, 2011. ,
DOI : 10.1128/AAC.01128-10
URL : https://hal.archives-ouvertes.fr/hal-00818523
Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.3239-3282 ,
DOI : 10.1128/AAC.00019-12
Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3264-73, 2005. ,
DOI : 10.1128/AAC.49.8.3264-3273.2005
Echinocandin resistance, Current Opinion in Infectious Diseases, vol.27, issue.6, pp.484-92, 2014. ,
DOI : 10.1097/QCO.0000000000000111
isolates from two university hospitals in Germany and Austria, Mycoses, vol.54, issue.5, pp.312-320, 2016. ,
DOI : 10.1128/AAC.00836-10
Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin, Antimicrobial Agents and Chemotherapy, vol.60, issue.8, pp.5088-91, 2016. ,
DOI : 10.1128/AAC.00630-16
URL : https://hal.archives-ouvertes.fr/hal-01367142
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata, Journal of Clinical Microbiology, vol.50, issue.4, pp.1199-203 ,
DOI : 10.1128/JCM.06112-11
Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance, Antimicrobial Agents and Chemotherapy, vol.58, issue.12, pp.7601-7606, 2014. ,
DOI : 10.1128/AAC.04134-14
Clinical and epidemiological changes of candidemia among adult patients from 2000 to 2013]. Rev Chil Infectologia Organo Of Soc Chil Infectologia, Feb, vol.34, issue.1, pp.19-26, 2017. ,
The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study, BMC Infectious Diseases, vol.58, issue.Suppl 1, p.609, 2014. ,
DOI : 10.1016/j.jinf.2008.12.008
High-Throughput Identification of Bacteria and Yeast by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Conventional Medical Microbiology Laboratories, Journal of Clinical Microbiology, vol.48, issue.3, pp.900-907, 2010. ,
DOI : 10.1128/JCM.02071-09
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections, Clinical Microbiology and Infection, vol.21, issue.4, pp.372-380 ,
DOI : 10.1016/j.cmi.2014.11.009
Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Routine Identification of Yeast, Journal of Clinical Microbiology, vol.49, issue.4, pp.1614-1620, 2011. ,
DOI : 10.1128/JCM.02381-10
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species, Journal of Clinical Microbiology, vol.48, issue.5, pp.1592-1601, 2010. ,
DOI : 10.1128/JCM.02445-09
Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012, Journal of Clinical Microbiology, vol.50, issue.9, pp.2846-56, 2012. ,
DOI : 10.1128/JCM.00937-12
Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme, Clinical Microbiology and Infection, vol.19, issue.8, pp.343-353, 2013. ,
DOI : 10.1111/1469-0691.12212
Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study, Mycoses, vol.18, issue.5, pp.296-303, 2016. ,
DOI : 10.1111/1469-0691.12038
Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study, PLOS ONE, vol.54, issue.8, p.127534, 2015. ,
DOI : 10.1371/journal.pone.0127534.t005
Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011, Clinical Infectious Diseases, vol.55, issue.10, pp.1352-61, 2008. ,
DOI : 10.1093/cid/cis697
Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study, European Journal of Clinical Microbiology & Infectious Diseases, vol.49, issue.3, pp.501-508, 2017. ,
DOI : 10.2307/1937887
spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study, Mycoses, vol.56, issue.13, 2017. ,
DOI : 10.1128/AAC.00355-12
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008???2009), International Journal of Antimicrobial Agents, vol.38, issue.1, pp.65-74, 2008. ,
DOI : 10.1016/j.ijantimicag.2011.02.016
No increase in primary nosocomial candidemia in 682 German intensive care units during, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.18, issue.24, 2006. ,
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study), Haematologica, vol.100, issue.2, pp.284-92, 2015. ,
DOI : 10.3324/haematol.2014.113399
Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031) Clin Infect Dis Off Publ Infect Dis Soc Am, pp.324-355, 2015. ,
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report, Haematologica, vol.102, issue.10, pp.407-417, 2017. ,
DOI : 10.3324/haematol.2017.172536
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.63, issue.4, pp.1-60, 2016. ,
DOI : 10.1093/cid/ciw326
CAND-LO 2014???15 study: changing epidemiology of candidemia in Lombardy (Italy), Infection, vol.33, issue.6, pp.765-80, 2016. ,
DOI : 10.1007/s10096-014-2096-9
Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study, Mycoses, vol.87, issue.6, pp.664-71, 2013. ,
DOI : 10.1016/S0002-9343(89)80392-4
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? Clin Infect Dis [Internet] Available from: http://paperity.org/p/42773222/candidemia- subsequent-to-severe-infection-due-to-clostridium-difficile-is-there-a-link, 2013. ,
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection, Clinical Microbiology and Infection, vol.21, issue.5, pp.493-494, 2015. ,
DOI : 10.1016/j.cmi.2014.12.024
Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species, Diagnostic Microbiology and Infectious Disease, vol.80, issue.3, 2014. ,
DOI : 10.1016/j.diagmicrobio.2014.07.012
Epidemiology and prognosis of candidaemia in elderly patients. Mycoses, 2017. ,
Global trends in the distribution of Candida species causing candidemia, Clinical Microbiology and Infection, vol.20, issue.6, pp.5-10 ,
DOI : 10.1111/1469-0691.12539
Relative frequency of albicans and the various nonalbicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review, Int J Infect Dis IJID Off Publ Int Soc Infect Dis, vol.14, issue.11, pp.954-966, 2010. ,
National Surveillance of Fungemia in Denmark (2004 to 2009), Journal of Clinical Microbiology, vol.49, issue.1, pp.325-359, 2004. ,
DOI : 10.1128/JCM.01811-10
Candidemia in patients with hematologic malignancies in the era of new antifungal agents): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer, pp.4745-52, 1920. ,
Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001???2010, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.533-541, 2001. ,
DOI : 10.1016/j.ijantimicag.2012.07.022
Epidemiology of Candida kefyr in Patients with Hematologic Malignancies, Journal of Clinical Microbiology, vol.52, issue.6, pp.1830-1837 ,
DOI : 10.1128/JCM.00131-14
Global trends in the distribution of Candida species causing candidemia, Clinical Microbiology and Infection, vol.20, issue.6, pp.5-10 ,
DOI : 10.1111/1469-0691.12539
Drug-Resistant Candida glabrata Infection in Cancer Patients Number 11?November 2014 -Emerging Infectious Disease journal -CDC. [cited 2017 Oct 15]; Available from: https://wwwnc.cdc.gov/eid/article, pp.14-0685 ,
Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study, Clinical Microbiology and Infection, vol.21, issue.10, pp.946-53, 2015. ,
DOI : 10.1016/j.cmi.2015.06.010
A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia, Haematologica, vol.93, issue.4, pp.581-588, 2008. ,
DOI : 10.3324/haematol.11882
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance??) registry, 2004???2008, Diagnostic Microbiology and Infectious Disease, vol.74, issue.4, pp.323-354, 2004. ,
DOI : 10.1016/j.diagmicrobio.2012.10.003
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.1695-703, 2009. ,
Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France, Antimicrobial Agents and Chemotherapy, vol.55, issue.11, pp.5358-61, 2011. ,
DOI : 10.1128/AAC.00690-11
URL : https://hal.archives-ouvertes.fr/hal-00818510
Antifungal use influences Candida species distribution and susceptibility in the intensive care unit, Journal of Antimicrobial Chemotherapy, vol.66, issue.12, pp.2880-2886, 2011. ,
DOI : 10.1093/jac/dkr394
URL : https://hal.archives-ouvertes.fr/hal-00818509
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment, The American Journal of Medicine, vol.125, issue.1, pp.3-13 ,
DOI : 10.1016/j.amjmed.2011.11.001
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences, The Lancet Infectious Diseases, vol.2, issue.2, pp.73-85, 2002. ,
DOI : 10.1016/S1473-3099(02)00181-0
Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans, International Journal of Antimicrobial Agents, vol.42, issue.5, pp.410-415, 2013. ,
DOI : 10.1016/j.ijantimicag.2013.07.013
Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates. Eukaryot Cell, 2007. ,
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.61, issue.10, 2017. ,
DOI : 10.1128/AAC.00906-17
Available from, Global Report on Surveillance. [Internet], pp.62-66, 2014. ,
Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata, Journal of Clinical Microbiology, vol.44, issue.5, pp.1740-1743, 2006. ,
DOI : 10.1128/JCM.44.5.1740-1743.2006
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex, BMC Infectious Diseases, vol.45, issue.1, p.387, 2009. ,
DOI : 10.1086/520980
In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods, Journal of Clinical Microbiology, vol.47, issue.10, 2009. ,
DOI : 10.1128/JCM.00942-09
The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp., Journal of Antimicrobial Chemotherapy, vol.72, issue.7, pp.1969-76, 2017. ,
DOI : 10.1093/jac/dkx010
Mechanisms of echinocandin antifungal drug resistance, Annals of the New York Academy of Sciences, vol.333, issue.Suppl 7, pp.1-11 ,
DOI : 10.1126/science.1206412
Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment, Antimicrobial Agents and Chemotherapy, vol.58, issue.7, pp.3626-3661 ,
DOI : 10.1128/AAC.00123-14
Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure, Antimicrobial Agents and Chemotherapy, vol.57, issue.9, pp.4559-61, 2013. ,
DOI : 10.1128/AAC.01144-13
Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program Available from: https, Open Forum Infect Dis, vol.2, issue.4, 2008. ,
Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations, Antimicrobial Agents and Chemotherapy, vol.56, issue.5, pp.2435-2477, 2012. ,
DOI : 10.1128/AAC.06369-11
Mutations among Consecutive Candida Isolates Causing Bloodstream Infection, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7465-70, 2015. ,
DOI : 10.1128/AAC.01973-15
The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata, Antimicrobial Agents and Chemotherapy, vol.56, issue.9, pp.4862-4871, 2012. ,
DOI : 10.1128/AAC.00027-12
Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance, Nature Communications, vol.3, p.11128, 2016. ,
DOI : 10.1111/j.1365-2958.2012.08194.x
Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study, Antimicrobial Agents and Chemotherapy, vol.60, issue.3, pp.1500-1508, 2016. ,
DOI : 10.1128/AAC.01763-15
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus- United States, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.17, issue.1, pp.2017296-2017305, 2013. ,
Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin, Antimicrobial Agents and Chemotherapy, vol.57, issue.5, pp.2380-2382 ,
DOI : 10.1128/AAC.02037-12
Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7715-7737, 2015. ,
DOI : 10.1128/AAC.02204-15
Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, J Clin Microbiol, 2001. ,
Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience. Infect Drug Resist, pp.199-205, 2015. ,
Candida glabrata candidemia: An emerging threat in critically ill patients. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med, 2015. ,
Predictors of Adverse Outcome in Cancer Patients with Candidemia 11Supported by a grant from Pfizer Pharmaceuticals, Inc., The American Journal of Medicine, vol.104, issue.3, pp.238-283, 1998. ,
DOI : 10.1016/S0002-9343(98)00030-8
Management of Central Venous Catheters in Patients with Cancer and Candidemia, Clinical Infectious Diseases, vol.38, issue.8, pp.1119-1146, 2004. ,
DOI : 10.1086/382874
Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003, Journal of Clinical Microbiology, vol.43, issue.4, pp.1829-1864, 2002. ,
DOI : 10.1128/JCM.43.4.1829-1835.2005
Nationwide Trends of Severe Sepsis in the 21st Century (2000???2007), Chest, vol.140, issue.5, pp.1223-1254, 2000. ,
DOI : 10.1378/chest.11-0352
Changes in case-mix and outcomes of critically ill patients in an Australian tertiary intensive care unit. Anaesth Intensive Care, pp.703-712, 2010. ,
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*, Critical Care Medicine, vol.41, issue.5, pp.1167-74, 2013. ,
DOI : 10.1097/CCM.0b013e31827c09f8
Two Decades of Mortality Trends Among Patients With Severe Sepsis, Critical Care Medicine, vol.42, issue.3, 2014. ,
DOI : 10.1097/CCM.0000000000000026